Crocus Technology Unveils 2nd Gen TMR Linear Sensor with Unparalleled Temperature Stability Crocus Technology Inc., a leading supplier of disruptive Tunnel Magneto-Resistance (TMR) sensors, today announces the CT100 device, an advanced, high-performance linear (1D) magnetic sensor based on Crocus’ patented … Continued
Twist Bioscience Showcases Next-Generation Sequencing Solutions at the 2019 Advances in Genome Biology and Technology Meeting Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced … Continued
Selecta Biosciences Announces Pricing of Public Offering of Common Stock Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform technology, ImmTOR (SVP Rapamycin), today announced the … Continued
Natron Energy Announces Strategic Investment by Chevron Technology Ventures Natron Energy, a developer and provider of disruptive new battery products using Prussian Blue electrode chemistry, has closed a strategic investment by Chevron Technology Ventures (CTV) to support the development of … Continued
SQZ Biotech Strengthens Leadership Team with Appointment of Chief Medical Officer Industry veteran, Oliver Rosen, MD, to join executive team as SQZ prepares to enter the clinic SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic … Continued
Selecta Biosciences Expands Potential for ImmTOR™ Platform and Streamlined Structure Under Leadership of New CEO, Carsten Brunn, Ph.D. Reported completion of SEL-212 Phase 2 study with positive efficacy and tolerability results observed in the clinical trial, in addition to monthly … Continued
Existing investors contribute an additional $30 million to Inscripta to accelerate tools that will revolutionize genomic research Inscripta™, a leading gene-editing technology company, today announced that MAD7, its proprietary CRISPR enzyme, has achieved wide adoption by academic, commercial, and government … Continued
Inscripta’s MAD7 Named a Top Innovation of 2018 by The Scientist Gene editing has immense potential to advance and accelerate research of all kinds. Despite this, its potential to transform the world as we know it is limited by a … Continued
Crocus Technology Inc. Unveils Industry-Leading TMR-based Angular Sensor Crocus Technology Inc., a leading supplier of disruptive Tunnel Magneto-Resistance (TMR) sensors, today announces the CT300 device, a new break-through TMR-based angular (2D) magnetic sensor with an extremely low angular error and … Continued
SQZ Biotech expands cell therapy partnership with Roche to develop antigen presenting cells for immune-oncology SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the expansion of its collaboration with Roche (SIX: RO, … Continued